Genmab A (GMAB) Non-Current Assets (2018 - 2026)

Genmab A (GMAB) posted Non-Current Assets of $9.8 billion for Q1 2026, down 1.85% on a QoQ basis from $10.0 billion in Q4 2025, and up 284.58% year-over-year from $2.5 billion in Q1 2025.

Genmab A (GMAB) Non-Current Assets (2018 - 2026) Analysis & Trends

Genmab A's Non-Current Assets history runs 7 years deep, the most recent figure standing at $9.8 billion for Q1 2026.

  • Quarterly Non-Current Assets rose 284.58% year-over-year to $9.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 billion (up 75.02% YoY) and the FY2025 annual result came in at $10.0 billion, up 297.3% from the prior year.
  • Non-Current Assets was $9.8 billion for Q1 2026 at Genmab A, down from $10.0 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $10.0 billion in Q4 2025 and bottomed at $320.0 million in Q4 2023.
  • A 4-year average of $3.7 billion and a median of $2.5 billion in 2025 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Non-Current Assets jumped 685.62% — and 2025, when it climbed 6.38%.
  • Genmab A's Non-Current Assets stood at $320.0 million in 2023, then soared by 685.62% to $2.5 billion in 2024, then soared by 297.3% to $10.0 billion in 2025, then decreased by 1.85% to $9.8 billion in 2026.
  • Business Quant data shows GMAB's Non-Current Assets at $9.8 billion in Q1 2026, $10.0 billion in Q4 2025, and $2.6 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Genmab A 1.89 Bn 366.92 Mn 831.00 Mn 9.80 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.80 Bn
Dec 31, 2025 9.99 Bn
Sep 30, 2025 2.55 Bn
Jun 30, 2025 2.55 Bn
Mar 31, 2025 2.55 Bn
Dec 31, 2024 2.51 Bn
Sep 30, 2024 2.40 Bn
Mar 31, 2024 335.00 Mn
Dec 31, 2023 320.00 Mn
Sep 30, 2020 2,018.00
Dec 31, 2019 1,074.00
Sep 30, 2019 1.07 Bn
Dec 31, 2018 831.75 Mn